Immunity Inflammation and Disease journal

IID has received its impact factor! Impact factor: 2.5 2019 Journal Citation Reports (Clarivate Analytics): 112/158 (Immunology) Many thanks to all authors for the trust and reviewers for their vital work.

Nouvelle publication du Dr Stéphanie Pons sur la thématique de l'immunomodulation par les cellules endothéliales dans le cadre du sepsis. Bravo ! onlinelibrary.wiley.com/doi/full/10.10… @ImmunityAnd @SFAR_ORG @La_SRLF @APHP

CCL17-expressing #dendritic #cells in the intestine are preferentially infected by #Salmonella but #CCL17 plays a redundant role in systemic dissemination @FoersterLab @UniBonn @ImmunityAnd bit.ly/3jFw24k

Our #research study published in @ImmunityAnd uncovered a #breakthrough in treating #respiratory #inflammation #sorethroat and found that common OTC drugs are causing more harm than good. businesswire.com/news/home/2021…

📢Thanks to @iuis_online for providing registration grants to attend the @2021ECI ! To be in with a chance of getting waived registration: 1. Submit an abstract by May 24 🔗buff.ly/3haoENs 2. Apply for a grant @EFIS_Immunology 🔗buff.ly/3byvGs4

Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. secure.wiley.com/openaccess @wileyinresearch

Check out our latest paper showing #GCSF is not pathogenic (and maybe protective?) in #lupus published in Immunity, Inflammation and Disease @ImmunityAnd doi.org/10.1002/iid3.4…

Ahead of print: CCL17-expressing #dendritic cells in the #intestine are preferentially infected by #Salmonella but #CCL17 plays a redundant role in #systemic #dissemination @ImmunityAnd #FörsterLab @TheDohertyInst bit.ly/3eYTpCF

Now available: check out the March issue of the #OpenAccess journal Immunity, Inflammation and Disease: ow.ly/2EEx50DGsZa @ImmunityAnd

Do review please. You may learn something new, ensure quality and robustness in your field. But be on time. Support your field. If nobody is willing to review, nothing will be published and the field will be poorer for it. Don´t expect others to do the reviewing, if you don´t.

Remember as authors; choose your potential reviewer carefully: not your friends nor those that are unlikely to look at your manuscript. Add as many potential reviewers to Manuscript central. All scientists are busy and may not have time when you submit an manuscript.

Lots of authors are publishing #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has #OA agreements with many countries and regions. Check to see if you're eligible. secure.wiley.com/openaccess

Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. secure.wiley.com/openaccess @wileyinresearch

Good news! You may be able to publish #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has agreements with many countries and regions. Check if you’re eligible. secure.wiley.com/openaccess

Excellent paper generating good interest: onlinelibrary.wiley.com/doi/full/10.10… Check it out!

IL-6 signaling requires only few interleukin-6 molecules: Relation to physiological concentrations of extracellular IL-6. Understand what a given plasma concentration of a cytokine signifies. Out in IID soon! @Morten_Bagge

Excellent new paper accepted. In biopsies, upregulation of DNASE1L3 in asthma and IL1B in neutrophilic asthma similar to previously findings in sputum. Coming online soon on onlinelibrary.wiley.com/journal/205045… @SSanchezOvando

Excellent issue number 3, September 2019, online now! onlinelibrary.wiley.com/toc/20504527/2…